The treatment landscape of metastatic hormone-sensitive prostate cancer (mHSPC) has changed radically in recent years. Androgen deprivation therapy (ADT) alone was for decades the …

Treatment of metastatic prostate cancer is generally based on whether its growth can be slowed or stopped with hormone therapy. Recall that testosterone (an androgen hormone) is the “fuel” …

Early Evaluation Clinicians SHOULD Obtain tissue diagnosis from primary tumor or site of metastases when clinically feasible in patients without prior histologic confirmation Discuss …

Annually, >1.2 million new cases of prostate cancer are diagnosed and global prostate cancer-related deaths exceed 350 000 per annum, making it one of the leading causes of cancer …

The treatment landscape of advanced prostate cancer continues to evolve, particularly over the last 5+ years. Although there are several treatment options, including both ADT-based doublet …

Purpose: To summarize contemporary and emerging strategies for the diagnosis and management of metastatic hormone sensitive prostate cancer (mHSPC), focusing on …

When prostate cancer spreads beyond the prostate or returns after treatment, it is often called advanced prostate cancer. There are many ways to control advanced prostate cancer. …

What are the signs of advanced prostate cancer? Learn about symptoms, diagnosis, and treatment from the team at Advanced Urology Institute.

The standard treatment for metastatic hormone-sensitive prostate cancer (mHSPC) is now a combination of androgen deprivation therapy plus an androgen receptor-targeted therapy …

Treatment options for advanced prostate cancer Once prostate cancer has reached an advanced stage or metastasized to the bones, it may be non-responsive to hormone therapy as well as …